MedTrace Logo

Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients

NCT00233142 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2016-04-15

No results posted yet for this study

Summary

This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.

Conditions

Interventions

BEHAVIORAL

Expressive writing

Writing as therapeutic intervention

BEHAVIORAL

Neutral writing

Non-expressive writing

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Syracuse University

    lead OTHER

Principal Investigators

  • Joshua M. Smyth, PhD · Syracuse University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00233142 on ClinicalTrials.gov